Zobrazeno 1 - 10
of 512
pro vyhledávání: '"Phosphodiesterase Type 5 Inhibitor"'
Autor:
Tilmann Kramer, Phillip Nattmann, Felix Gerhardt, Patrycja Stafiej, Daniel Dumitrescu, Henrik tenFreyhaus, Max Wißmüller, Christopher Hohmann, Stephan Baldus, Stephan Rosenkranz
Publikováno v:
ESC Heart Failure, Vol 11, Iss 3, Pp 1540-1552 (2024)
Abstract Aims In pulmonary arterial hypertension (PAH), upfront combination therapy with ERA and PDE5i is associated with a reduction in morbidity and mortality events and improves standard haemodynamics, but data remain limited. Aims of this study w
Externí odkaz:
https://doaj.org/article/f23f54b13e534e42bb0d15185320ae04
Iatrogenic esophageal dysmotility as a barrier to transplantation in pulmonary arterial hypertension
Autor:
Michael S. Miller, Shelsey W. Johnson, Alexander R. Opotowsky, Michael J. Landzberg, Nirmal S. Sharma, Hilary J. Goldberg, Alexandra K. Wong, Alison S. Witkin, Josanna Rodriguez-Lopez, Ronald H. Goldstein, Bradley A. Maron, Bradley M. Wertheim
Publikováno v:
JHLT Open, Vol 5, Iss , Pp 100098- (2024)
Esophageal dysmotility is identified as a contraindication to lung transplantation at some centers due to increased risks of acute rejection, pulmonary infection, and chronic lung allograft dysfunction. Phosphodiesterase-type 5 inhibitors (PDE5i) are
Externí odkaz:
https://doaj.org/article/4145d27170eb4e76b982c3e6fb360f36
Autor:
Kurt Miller, Uwe May, Wolf-Dietrich Beecken, Georgios Hatzichristodoulou, Michael Böhm, Stefan Fink
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
An evidence-based consensus meeting was held with urologists, a pharmacist and a cardiologist to perform a structured benefit-risk analysis of reclassifying tadalafil, a phosphodiesterase type 5 (PDE5) inhibitor for treatment of erectile dysfunction
Externí odkaz:
https://doaj.org/article/cbd36f2815c04b41b7c11af8a38d2d05
Autor:
Daisuke Gotoh, Kazumasa Torimoto, Yosuke Morizawa, Shunta Hori, Yasushi Nakai, Makito Miyake, Kiyohide Fujimoto
Publikováno v:
BMC Research Notes, Vol 15, Iss 1, Pp 1-6 (2022)
Abstract Objective To evaluate the efficacy and safety of add-on therapy with the phosphodiesterase type 5 inhibitor tadalafil in Japanese men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with dutasteride
Externí odkaz:
https://doaj.org/article/9a148b5d43f4466ea4872488e89e3ffd
Autor:
Jessica Liauw, Katie Groom, Wessel Ganzevoort, Christian Gluud, Christopher J. D. McKinlay, Andrew Sharp, Laura Mackay, Chirag Kariya, Ken Lim, Peter von Dadelszen, Jacqueline Limpens, Janus C. Jakobsen, the STRIDER Consortium
Publikováno v:
Systematic Reviews, Vol 10, Iss 1, Pp 1-11 (2021)
Abstract Background Early onset fetal growth restriction secondary to placental insufficiency can lead to severe maternal and neonatal morbidity and mortality. Pre-clinical studies and a few small randomised clinical trials have suggested that phosph
Externí odkaz:
https://doaj.org/article/79c934a25fd948e0a218890e5020aafc
Autor:
Thibault Petit, Guido Claessen, Mathias Claeys, Andre La Gerche, Piet Claus, Stefan Ghysels, Marion Delcroix, Agnieszka Ciarka, Walter Droogne, Johan Van Cleemput, Rik Willems, Jens‐Uwe Voigt, Jan Bogaert, Stefan Janssens
Publikováno v:
ESC Heart Failure, Vol 8, Iss 6, Pp 4661-4673 (2021)
Abstract Aims Identifying early right ventricular (RV) dysfunction and impaired vasodilator reserve is challenging in heart failure with preserved ejection fraction (HFpEF). We hypothesized that cardiac magnetic resonance (CMR)‐based exercise imagi
Externí odkaz:
https://doaj.org/article/81ec1ecfaa7f4f7ea2016cb55be18a71
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Seung-Hun Song, Dong Hyuk Shin, Young Sun Her, Mi Hee Oh, Jung Won Baek, Suye Sung, Jin Hee Eum, Yohan Heo, Dong Suk Kim
Publikováno v:
Investigative and Clinical Urology, Vol 62, Iss 3, Pp 354-360 (2021)
Purpose: Phosphodiesterase type 5 (PDE5) inhibitors are effective treatments for erectile dysfunction, and several recent studies have reported positive effects of PDE5 inhibitors on semen parameters as well. However, the data are still controversial
Externí odkaz:
https://doaj.org/article/b91dd143e7c441b688868f08a7948ab9
Autor:
Abdulaziz Bakhsh, MD, MBA, Tareef Daqqaq, MD, Ayman Alhasan, MD, Mansour Alnazari, MD, Emad Rajih, MD, MPH
Publikováno v:
Sexual Medicine, Vol 8, Iss 2, Pp 318-322 (2020)
Introduction: Cavernositis is a rare acute infection of the corporal bodies of the penis. It might result in corporal cavernosal abscesses, fibrosis, and subsequently erectile dysfunction if the treatment is inadequate. Previous reports advocate peni
Externí odkaz:
https://doaj.org/article/c2501ff7eb7a452e899bc117951cbf7d